Daiichi defers open offer for Ranbaxy

-

Delay in Sebi approval prompts move.

 Japanese drug major Daiichi Sankyo today deferred its proposed open offer to acquire an additional 20 per cent stake in Ranbaxy Laboratories, citing a delay in approvals from market regulator Securities & Exchange Board of India (Sebi).

In a communication to the Bombay Stock Exchange (BSE) today, ICICI Securities, which is managing the open offer on behalf of Daiichi Sankyo, said a new date would be announced later. "The revised schedule of activities will be announced separately after receiving Sebi's observations," said the announcement.

The open offer was scheduled to start on August 8 and close on August 27, as per an announcement on June 16. A Ranbaxy spokesperson said the deal is on track and the terms and conditions announced earlier would remain the same. "The delay in the open offer is procedural in nature. The revised date of open offer will be communicated soon", he said.

Under the rules, Sebi is supposed to get back within 21 days of the open offer application. When contacted, Sebi sources said it will approve the issue after some "procedural queries" are sorted out.

ICICI Securities said the draft Letter of Offer was submitted to the market regulator on June 27, 2008 as per the regulations and was awaiting approval from the regulator. The proposal is to acquire up to 92,519,126 equity shares of a face value of Rs 5 each from the non-promoter shareholders of Ranbaxy, at a target price of Rs 737.

The announcement comes at a time when Ranbaxy has been in the news for alleged irregularities in complying with the United States Food and Drug Administration norms.

Ranbaxy's promoters, Malvinder Singh and his family, had decided on June 11 to sell off their 34.6 per cent stake in the company to the Japanese drug major in a deal valued about Rs.10,000 crore. Daiichi had said it would follow up with an open offer to acquire a further 20 per cent stake in Ranbaxy and its subsidiary Zenotech

Popular posts from this blog

IOB capitalises on hike in stake by LIC

-
Indian Overseas Bank rose 1.53% to Rs 46.45 at 10:31 IST on BSE, after the biggest domestic instutional investors Life Insurance Corporation of India hiked its stake in the state-run bank. The bank made this announcement after trading hours on Wednesday, 25 March 2009. Meanwhile, the BSE Sensex was up 126.19 points, or 1.31%, to 9,794.09. On BSE, 31,003 shares were traded in the counter. The stock had an average daily volume of 1.93 lakh shares in the past one quarter. The stock hit a high of Rs 47 and a low of Rs 45.95 so far during the day. The stock hit a 52-week high of Rs 156.80 on 2 May 2008 and a 52-week low of Rs 37.55 on 9 March 2009. The mid-cap bank stock had underperformed the market over the past one month till 25 March 2009, falling 3.17% as compared to the Sensex's 8.60% rise. It had also underperformed the market in the past one quarter, declining 33.94% as compared to the Sensex's 1.04% rise. The bank's current equ The current price of ...
Read more

Lok Housing & Constructions builds on fund raising plans

-
Lok Housing & Constructions jumped 6.99% to Rs 107.90 at 11:20 IST on BSE ahead of a board meeting to consider fund raising options from both foreign and local market, including an institutional placement. Meanwhile, the BSE Sensex was down 50.50 points, or 0.30%, at 15203.73. On BSE, 1.86 lakh shares were traded in the counter. The scrip had an average daily volume of 4.74 lakh shares in the past one quarter. The stock hit a high of Rs 115 and a low of Rs 102 so far during the day. The stock had a 52-week high of Rs 390.50 on 1 January 2008 and a 52-week low of Rs 96.25 on 12 June 2008. The scrip had underperformed the market over the past one month till 12 June 2008, falling 26.55% compared to the Sensex's 10.18% decline. It had also underperformed the market in the past one quarter, falling 31.39% compared to Sensex's 3.24% fall. The small-cap housing projects developer has an equity capital of Rs 42.88 crore. Face value per share is Rs 10. The current...
Read more

Griffin Chemicals surges on re-listing

-
Griffin Chemicals was trading at Rs 29, up 2220% on re-listing after six years on Bombay Stock Exchange (BSE). The counter saw miniscule volume of 4769 shares. The stock opened at Rs 23, up 1740% against its last traded price of Rs 1.25 on 8 August 2002. The Griffin Chemicals stock was highly volatile today. It opened at Rs 23 and then rallied ahead to Rs 50 but soon eased to a low Rs 22. The surge in Griffin shares reminds of unprecedented rise in stock prices of KGN Industries on its re-listing day. KGN Industries, run by Ahmedabad-based Memon family, had re-listed at Rs 100 per share after nearly seven years in May 2008 this year. The stock had risen to a high of Rs 55,000.
Read more